Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Short-term Investments: 2020-2021

Historic Short-term Investments for Black Diamond Therapeutics (BDTX) over the last 2 years, with Sep 2021 value amounting to $188.4 million.

  • Black Diamond Therapeutics' Short-term Investments fell 31.95% to $188.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $188.4 million, marking a year-over-year decrease of 31.95%. This contributed to the annual value of $280.5 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Short-term Investments is $188.4 million, which was down 16.69% from $226.1 million recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Short-term Investments high stood at $280.5 million for Q4 2020, and its period low was $140.5 million during Q2 2020.
  • Over the past 2 years, Black Diamond Therapeutics' median Short-term Investments value was $251.0 million (recorded in 2021), while the average stood at $231.4 million.
  • Within the past 5 years, the most significant YoY rise in Black Diamond Therapeutics' Short-term Investments was 60.95% (2021), while the steepest drop was 31.95% (2021).
  • Quarterly analysis of 2 years shows Black Diamond Therapeutics' Short-term Investments stood at $280.5 million in 2020, then plummeted by 31.95% to $188.4 million in 2021.
  • Its Short-term Investments was $188.4 million in Q3 2021, compared to $226.1 million in Q2 2021 and $275.9 million in Q1 2021.